1-(6-Chloropyridin-2-yl)-2,2,2-trifluoroethanone, 98%, 250mg

3-(Chloromethyl)isoquinoline, 95.0%, 250mg

(E)-2-(1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)acetonitrile, 97%, 100g

3-Bromopropyl Acetate>95.0%(GC)5g

Ethyl 7-(4-Chloro-2-methoxyphenyl)-7-oxoheptanoate, 97.0%, 1g

Potassium 1-(2-(dimethylamino)ethyl)-1H-pyrazole-5-carboxylate, 97.0%, 1g

Methyl 4-nitrobenzene-1-sulfonate, 95.0%, 10g

(2R,3S,5R)-2-(2,5-DIFLUOROPHENYL)-5-[2-(METHYLSULFONYL)-2,6-DIHYDROPYRROLO[3,4-C]PYRAZOL-5(4H)-YL]TETRAHYDRO-2H-PYRAN-3-AMINE, 95.0%, 5g

2',4'-Dimethoxybiphenyl-3-carboxylic acid, 250mg

Óxido de cobre(I), mínimo 97 %, rojo, polvo, 500 g, envase de vidrio

5-Fluoro-6-hydroxy-2-methyl-4(1H)-pyrimidinone, 95.0%, 1g

Ethyl 2-(1H-indol-2-yl)acetate, 95.0%, 5g

3-Fluoro-2-hydrazinyl-5-(trifluoromethyl)pyridine, 95%, 100mg